{"id":20143,"date":"2012-07-16T12:00:52","date_gmt":"2012-07-16T11:00:52","guid":{"rendered":"http:\/\/www.transcend.org\/tms\/?p=20143"},"modified":"2012-07-14T18:22:40","modified_gmt":"2012-07-14T17:22:40","slug":"glaxosmithkline-fraud-case-does-crime-pay","status":"publish","type":"post","link":"https:\/\/www.transcend.org\/tms\/2012\/07\/glaxosmithkline-fraud-case-does-crime-pay\/","title":{"rendered":"GlaxoSmithKline Fraud Case: Does Crime Pay?"},"content":{"rendered":"

As the pharmaceutical giant is fined a record sum of $3bn, we ask if the move will be a deterrent for others.<\/em><\/p>\n

In the biggest health care fraud settlement in US history, a federal judge approved a fine totalling $3bn for criminal and civil violations by the British pharmaceutical giant, GlaxoSmithKline, last week.<\/p>\n

The company admitted illegally marketing the popular antidepressants Paxil and Wellbutrin and also withholding the data on the health risks of its best-selling diabetes drug, Avandia.<\/p>\n

For seven years Glaxo failed to report data showing drug Avandia increased the risk of heart attack by as much as 40 per cent.<\/p>\n

And the company claimed Wellbutrin was beneficial for weightloss and treating sexual dysfunction.<\/p>\n

In the case of Paxil, GlaxoSmithKline promoted the drug for use by children and teenagers, despite the US Food and Drug Administration not approving it for patients under 18.<\/p>\n

In fact, a clinical trial had found that the drug made adolecents more likely to attempt suicide.<\/p>\n

Whistleblowers said that the company gave doctors lavish trips and spa treatments in order to pursuade them to prescribe the drug for uses not approved of through testing – what are known as off-label prescriptions.<\/p>\n

Glaxo also hired a company to write a medical journal article downplaying the risks.<\/p>\n

The US deputy attorney general called the settlement historic, saying it sent a clear warning to any company that chooses to break the law.<\/p>\n

But there have been some other big drug companies that have been caught acting illegally.<\/p>\n

In January 2009, the American pharmaceutical giant Eli Lilly agreed to pay more than $1.4bn for illegally promoting the drug Zyprexa.<\/p>\n

Prior to Glaxo, the previous record-setting case involved Pfizer Inc., which in September 2009 paid $2.3bn for improperly marketing 13 different drugs, including Viagra.<\/p>\n

In April 2012, Johnson & Johnson and a subsidiary were ordered to pay more than $1.2bn for minimising or concealing dangers associated with the antipsychotic drug Risperdal.<\/p>\n

And in May, Abbott Laboratories settled for $1.6bn in regard to false marketing of the antiepileptic and mood-stabilising drug Depakote.<\/p>\n

So, with the profits over more than a decade of illegal selling far larger than the amount Glaxo agreed to pay, will pharmaceutical companies really be put off? And do drug companies put profits before patients in the US?<\/p>\n

“Many observers, including myself believe that as long as it is just money that’s involved, it’s not a sufficient deterrent. The drugs that were involved in this settlement earned tens of billions of dollars over a long period of time. So the settlement was less than a single year’s sales of just one of those drugs, Avandia, the drug that I was involved in exposing the risks of. And so it’s just money, and it’s just part of doing business. Many people, particularly on Capitol Hill, believe that it’s time to begin holding these executives accountable for actual jail time when they commit this kind of criminal fraud.”<\/em><\/p>\n

THE GLAXOSMITHKLINE FRAUD CASE:<\/strong><\/p>\n